STARCHES USE

Brand Owner (click to sort) Address Description
CLARIA EVERLAST TATE & LYLE TECHNOLOGY LIMITED 5 Marble Arch London W1H7EJ United Kingdom Starches for use in the manufacture of food and beverages;Starches for industrial purposes;
CLARIA TOP-GEL TATE & LYLE TECHNOLOGY LIMITED 5 Marble Arch London W1H7EJ United Kingdom Starches for use in the manufacture of food and beverages;Starches for industrial purposes;
EXTRUSAMYL COÖPERATIE AVEBE U.A. AVEBE-Weg 1 9607 PT FOXHOL Netherlands starches for use in the food industry;
EXTRUSAMYL Cooperatieve Verkoop- en Productievereniging van Aardappelmeel en Derivaten AVEBE B.A. Prins Hendrikplein 20, 9641 GK VEENDAM Netherlands starches for use in the food industry;
NOVACOLL AGRANA BETEILIGUNGS-AKTIENGESELLSCHAFT Friedrich-Wilhelm-Raiffeisen-Platz 1 A-1020 Wien Austria Starches for use in the manufacture of glues;The wording NOVACOLL has no meaning in a foreign language.;
STACKOTE INDOPCO, INC. 10 Finderne Avenue Bridgewater NJ 08807 Starches for use in the manufacture of paper, linerboard and coatings;
UNI-PUR' INDOPCO, INC. 10 Finderne Avenue Bridgewater NJ 08807 starches for use in the manufacture of pharmaceuticals;
UNI-PURE CORN PRODUCTS DEVELOPMENT, INC. 5 Westbrook Corporate Center Westchester IL 60154 starches for use in the manufacture of pharmaceuticals;
 

Where the owner name is not linked, that owner no longer owns the brand

    
Technical Examples
  1. An improved demineralized bone matrix (DBM) or other matrix composition is provided that has been mixed with a stabilizing agent that acts as (1) a diffusion barrier, (2) a enzyme inhibitor, (3) a competitive substrate, or (4) a masking moiety. A diffusion barrier acts as a barrier so as to protect the osteoinductive factors found in DBM from being degraded by proteolytic and glycolytic enzymes at the implantation site. Stabilizing agents may be any biodegradable material such as starches, modified starches, cellulose, dextran, polymers, proteins, and collagen. As the stabilizing agents degrades or dissolves in vivo, the osteoinductive factors such as TGF-?, BMP, and IGF are activated or exposed, and the activated factors work to recruit cells from the preivascular space to the site of injury and to cause differentiation into bone-forming cells. The invention also provides methods of preparing, testing, and using the inventive improved osteodinductive matrix compositions.